SINGAPORE, Feb. 28, 2025 /PRNewswire/ — This initiative targets to put together eco-friendly bio-based molecules from cheap, eco-friendly assets. Key advantages come with:
Price-parity with typical modes: In contrast to present bio-based molecules manufacturing, this initiative targets to succeed in cost-parity with typical processes via utilising cheap renewable assets like methanol.
Broad-ranging business programs: The sustainable bio-based molecules produced will also be impaired for wide-ranging business programs in textiles, automobile, non-public offer, and coatings industries.
Boosting Singapore’s inexperienced economic system: This try strengthens Singapore’s management within the international bioeconomy, which is able to govern to high-value task inauguration in sustainable biomanufacturing.
SINGAPORE – MojiaBio, a innovator in inexperienced chemistry and sustainable biomanufacturing, will likely be creating an SGD 44.8 million state of the art Sustainable Biomanufacturing Era Platform (SBTP) with the Company for Science, Era and Analysis (A*STAR). By means of integrating complicated artificial biology and bioprocessing inventions, the SBTP targets to place Singapore as a world chief in sustainable biomanufacturing, accelerating the transition to a round bioeconomy and net-zero while.
In contrast to alternative present bio-based molecules available in the market, the SBTP targets to pioneer the manufacturing of a area of high-value bio-based molecules which are cost-competitive and provide the desires of diverse industries. That is made imaginable because of the cutting edge utility of cost-effective assets like methanol and ethylene glycol, which allows the platform to put together scalable, sustainable choices to traditional chemical processes. This contains the manufacturing of one,3-propanediol (PDO), a key component for a wide array of industries akin to skin care merchandise, coatings and biodegradable plastics.
Development Singapore’s Functions in Inexperienced Biomanufacturing
The worldwide marketplace for inexperienced chemical substances is projected to succeed in USD 200 billion (round SGD 270 billion) via 2030, pushed via expanding call for for sustainable choices to their fossil-based opposite numbers. This collaboration will aid Singapore create up our artificial biology features, which can aid place us to seize a percentage of this rising marketplace and give a contribution to the improvement of unutilized financial alternatives within the inexperienced economic system.
On the middle of the SBTP is MojiaBio’s proprietary Cn+Bio™ pathway and OrthBio® bioconversion procedure, designed to transform cheap, renewable assets into bio-based molecules. This will likely be evolved in near collaboration with A*STAR Singapore Institute of Meals and Biotechnology Innovation (A*STAR SIFBI)—which can handover experience on enzyme engineering—to safeguard a sooner, extra worthy, and higher-yield conversion.
“The SBTP will not only produce bio-based molecules but also support downstream application research to synthesise high-value sustainable products for different industries,” mentioned Dr Ramon Gonzalez, MojiaBio CSO. “Through our partnership with A*STAR, we will be able to accelerate the commercialisation of green PDO to meet the growing demands and needs of the market.”
The SBTP leverages complicated artificial biology and integrates the Nationwide College of Singapore (NUS)’ computational modelling experience to engineer enzymes and microbial traces, optimising them as biocatalysts. In contrast to typical fermentation modes, the platform operates independently of its host mobile metabolism, which considerably complements power potency, scalability, and sustainability week decreasing manufacturing prices.
Schoolteacher Tan Sze Wee, Workman Government from A*STAR Biomedical Analysis Council mentioned, “The SBTP marks a significant step forward in sustainable biomanufacturing for Singapore, demonstrating how synthetic biology can unlock cost-effective productions of scalable value-added ingredient alternatives. By leveraging synthetic biology and enzyme engineering capabilities at A*STAR SIFBI and A*STAR Institute of Sustainability for Chemicals, Energy and Environment (A*STAR ISCE2) and forming strategic private-public partnerships, we are laying the foundation for further advancements in sustainable biomanufacturing across multiple industries. This collaboration will not only accelerate Singapore’s bioeconomy growth but also underscore our commitment to advancing in value-added ingredient innovation and green technologies.”
Lim Wey-Len, Government Vice President, Singapore Financial Building Board (EDB) mentioned: “Singapore has been developing our capabilities in industrial biotechnology as part of a push for sustainable manufacturing. The SBTP demonstrates how leading companies can partner Singapore’s research ecosystem to innovate and commercialise novel products that improve the quality of life, while meeting sustainability commitments. We welcome more like-minded companies to create solutions through Singapore that can further grow Asia’s bioeconomy sector.”
Advancing Inexperienced Economic system: Development a Sustainable Era In combination
The SBTP aligns with the Singapore Inexperienced Plan 2030 goals and international sustainability targets, akin to decreasing carbon emissions and selling a round economic system. In comparison to typical modes, bio-based molecules produced thru this platform deal important environmental advantages over typical processes, together with:
Decreased power utility: Renewable assets (e.g. methanol and ethylene glycol) require much less power to procedure.
Decrease carbon footprint: Bio-based manufacturing generally emits considerably much less carbon dioxide than typical chemical processes via round 60%.
Fewer pollution: Bio-based modes put together fewer damaging emissions, akin to nitrogen oxides (NOx) and sulphur oxides (SOx).
“This collaboration exemplifies our vision to create impactful, sustainable solutions for the future,” mentioned Dr Gonzalez. “MojiaBio is also making strides to establish our operational headquarters and a dedicated research laboratory in Singapore to accelerate commercialisation of other green chemicals to contribute to Singapore’s bioeconomy and the global transition toward sustainability.”
1 “Green Chemicals Market – Global Industry Assessment and Forecast.” Vantage Marketplace Analysis, 4 July 2023, www.vantagemarketresearch.com/industry-report/green-chemicals-market-1347.
In regards to the Company for Science, Era and Analysis (A*STAR)
The Company for Science, Era and Analysis (A*STAR) is Singapore’s govern nation sector R&D company. Via revealed innovation, we collaborate with our companions in each the nation and personal sectors to learn the economic system and people. As a Science and Era Organisation, A*STAR bridges the distance between academia and business. Our analysis creates economic expansion and jobs for Singapore, and complements lives via making improvements to societal results in healthcare, city dwelling, and sustainability. A*STAR performs a key function in nurturing clinical skill and leaders for the broader analysis crowd and business. A*STAR’s R&D actions span biomedical sciences to bodily sciences and engineering, with analysis entities essentially positioned in Biopolis and Fusionopolis.
About A*STAR Singapore Institute of Meals and Biotechnology Innovation (A*STAR SIFBI)
A*STAR Singapore Institute of Meals and Biotechnology Innovation (A*STAR SIFBI)’s perceptible is to be an innovation engine for fitness and well-being, specializing in the Asian phenotype. Our two strategic pillars are: 1) Creating sustainable, value-added components for meals and shopper offer; and a pair of) Optimizing fitness and wellbeing inside the Asian phenotype. We prioritize shopper acceptance, bearing in mind style, texture, and vitamin, along sustainable and secure meals manufacturing. Figuring out sensory personal tastes and the Asian phenotype lets in us to tailor meals designs to satisfy shopper wishes and give a boost to crowd fitness and wellness. We immediately affect meals resilience, crowd fitness, economic expansion, and ability construction. We envision Singapore as a hub for Asian meals and vitamin analysis, fostering business partnerships and regional collaboration to move this vital ground. That is completed thru public-private partnerships in the community and globally. Learn more about SIFBI.
About MojiaBio
MojiaBio is a pioneering chief in business biomanufacturing, revolutionizing the manufacturing of commodities, fabrics, and chemical substances thru sustainable and inexperienced processes. By means of leveraging state of the art applied sciences and demand-driven innovation, MojiaBio is dedicated to making transformative answers that surrounding the while of more than one industries. For more information on MojiaBio.
SOURCE MojiaBio
